Skip to main content
. Author manuscript; available in PMC: 2016 Nov 7.
Published in final edited form as: Pharmacol Ther. 2013 Nov 1;141(3):283–299. doi: 10.1016/j.pharmthera.2013.10.011

Table 1.

Evidence supporting a role for N/OFQ in obestity

Preparation Findings Reference
N/OFQ into brain of sated mice and rats Stimulation of feeding Olszewski and Levine, 2004
N/OFQ into the CNS of fat-prefering rats Stimulation of feeding Olszewski et al., 2002
N/OFQ into the CNS of rats Stimulation of c-fos expression in the NTS, PVN, central amygdala, lateral septum and habenular nuclei Olszewski et al., 2000
N/OFQ and N/OFQ agoinst Ro 64-6198 Inhibitition of anorectic effects of CRF N/OFQ Ciccocioppo et al., 2002; 2004
Chronic central administration of N/OFQ Increased body weight by inducing hyperphagia and by decreasing energy expenditure Matsushita et al., 2009
N/OFQ antagonist SB612111 Inhibition of fasting-induced feeding; effect absent in NOP receptor −/− mice Figure 2
Fasting in rats Reduces N/OFQ and ORL1/NOP gene expression within the CNS Rodi et al., 2002; Przydzial et al., 2009

DIO: diet-induced obese

NTS: nucleus of the solitary tract

PVN: paraventricular nucleus